Literature DB >> 32012221

Phenotype and function of circulating memory T cells in human vitiligo.

C Martins1, A-S Darrigade1,2, C Jacquemin1, T Barnetche3, A Taieb1,2, K Ezzedine4, K Boniface1,5, J Seneschal1,2,5.   

Abstract

BACKGROUND: Vitiligo is a chronic inflammatory skin disorder characterized by the loss of melanocytes. While a T helper cell (Th)1/cytotoxic T cell (Tc)1-skewed immune response is now well demonstrated in vitiligo, recent data suggest that the T-cell component could be more complex, involving different combinatorial T-cell subsets.
OBJECTIVES: To analyse the phenotype and function of circulating CD4+ and CD8+ memory T-cell subsets in patients with stable and active vitiligo, in comparison with patients with psoriasis and healthy controls.
METHODS: This is a monocentric, prospective, descriptive and exploratory study. Multiparametric flow cytometry analyses were performed to evaluate the surface expression of homing and T-cell-subset markers together with intracellular cytokine production in peripheral blood mononuclear cells from 60 patients with vitiligo, 25 patients with psoriasis and 28 healthy donors.
RESULTS: Vitiligo peripheral blood circulating effector and central memory T cells expressed similar proportions of skin-homing markers. Decrease in the frequencies of circulating CD4+ and CD8+ Th1/Tc1, Th17/Tc17, and Th1/Th17 or Tc1/Tc17 effector memory T-cell subsets were observed in patients with vitiligo compared with healthy donors. Similar observations were made in psoriasis. In contrast, vitiligo circulating T cells showed a similar capacity for proinflammatory cytokine production compared with those in psoriasis and healthy controls.
CONCLUSIONS: The decreased frequencies of circulating Th1/Tc1, Th17/Tc17 and Th1/Th17-Tc1/Tc17 cells suggest a possible migration of these T-cell subsets into the skin of patients with vitiligo. These could be targeted to prevent flares of the disease. What is already known about this topic? Vitiligo is a chronic inflammatory skin disorder associated with the loss of melanocytes. Vitiligo is characterized by a T helper cell (Th)1/cytotoxic T cell (Tc)1-skewed immune response in the skin. What does this study add? A thorough analysis of the phenotype and function of circulating memory T cells suggests the migration of Th1/Tc1, Th17/Tc17 and Th1/Th17-Tc1/Tc17 cell subsets in the skin. What is the translational message? A better understanding of the different immune T-cell subsets involved in vitiligo could lead to better therapeutic options. Linked Comment: Matos. Br J Dermatol 2020; 183:803.
© 2020 British Association of Dermatologists.

Entities:  

Mesh:

Year:  2020        PMID: 32012221     DOI: 10.1111/bjd.18902

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  5 in total

Review 1.  Vitiligo, From Physiopathology to Emerging Treatments: A Review.

Authors:  Laure Migayron; Katia Boniface; Julien Seneschal
Journal:  Dermatol Ther (Heidelb)       Date:  2020-09-19

2.  Is targeting circulating T blood cells a therapeutic option for vitiligo?

Authors:  T R Matos
Journal:  Br J Dermatol       Date:  2020-05-26       Impact factor: 9.302

Review 3.  Current Concepts of Vitiligo Immunopathogenesis.

Authors:  Nika Hlača; Tina Žagar; Marija Kaštelan; Ines Brajac; Larisa Prpić-Massari
Journal:  Biomedicines       Date:  2022-07-08

Review 4.  Strategies to Develop a Suitable Formulation for Inflammatory Skin Disease Treatment.

Authors:  Jiun-Wen Guo; Shiou-Hwa Jee
Journal:  Int J Mol Sci       Date:  2021-06-04       Impact factor: 5.923

5.  Altered circulating memory T cells in vitiligo cases followed NB-UVB therapy.

Authors:  Fuquan Lin; Xiukun Sun; Jiehao Lei; Ai-E Xu
Journal:  Photodermatol Photoimmunol Photomed       Date:  2021-07-27       Impact factor: 3.254

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.